Clinical trial
Seroprevalence and Vaccination Rate of Hepatitis B Virus and Varicella-zoster Virus Among Medical Students Under Immunizing Program
NCT06901362 is registered in ClinicalTrials.gov with Thammasat University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Seroprevalence and Vaccination Rate of Hepatitis B Virus and Varicella-zoster Virus Among Medical Students Under Immunizing Program
- Lead sponsor
- Thammasat University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2025
- Completion date
- November 30, 2025
- Enrollment
- 401 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy, healthy adult